Laurynas Leiteris

Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients

L. V. Van Laake, F. Asselbergs, N. de Jonge, 2020, ESC heart failure.

Pirfenidone Has Anti-fibrotic Effects in a Tissue-Engineered Model of Human Cardiac Fibrosis

M. Goumans, L. V. Van Laake, C. Bouten, 2022, Frontiers in Cardiovascular Medicine.

The circadian clock remains intact, but with dampened hormonal output in heart failure

P. Doevendans, Lu Zhang, Y. Devaux, 2023, EBioMedicine.

Cyclic strain has antifibrotic effects on the human cardiac fibroblast transcriptome in a human cardiac fibrosis-on-a-chip platform.

M. Goumans, C. Bouten, W. Suyker, 2023, Journal of the mechanical behavior of biomedical materials.